RxSight Inc (NASDAQ: RXST): Is It A Buying Opportunity Again?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. The stock was recently discussed on Yahoo Finance as it revealed that RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Stocks Info

RXST belongs to the Healthcare sector of the NASDAQ while operating in the Medical Devices industry. At the end of the last regular session, the stock closed at $49.77 and fluctuated between $51.14 as its day high and $49.03 as its day low. The current market capitalization of RxSight Inc is $1.78B. A total of 0.55 million shares were traded on the day, compared to an average of 0.98 shares.

Insider Activity

Investors also take into account insider trades in predicting how the stock will perform in the future. During the recent three months, RXST has seen 4 BUY and 5 SELL insider trades, representing the acquisition of 64,846 and the disposition of 587,735 shares. Over the last 12 months, there were 21 BUYs and 16 SELLs from insiders. Insiders purchased 370,625 shares during that period but sold 3,122,599.

In the most recent transaction, Thunen Shelley B sold 15,875 shares of RXST for 47.47 per share on Feb 06. After the transaction, the Chief Financial Officer now owns 13,691 company shares. In a previous transaction on Feb 05, Thunen Shelley B sold 9,125 shares at 47.02 per share. RXST shares that Chief Financial Officer owns now total 13,691.

Among the insiders who sold shares, LINK WILLIAM J PHD disposed of 28,250 shares on Feb 01 at a per-share price of $49.67. This resulted in the Director holding 24,248 shares of RXST after the transaction. In another insider transaction, Weinberg Eric sold 10,000 shares at $50.00 per share on Feb 01. Company shares held by the Chief Commercial Officer now total 299,978.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. According to analysts who have offered 12-month price targets for RXST in the last 3 months, the mean price target is $47.25 with high estimates of $54.00 and low estimates of $36.00. In terms of 52-week highs and lows, RXST has a high of $50.20 and a low of $12.24.

As of this writing, RXST has an earnings estimate of -$0.36 per share for the current quarter. EPS was calculated based on a consensus of 7 estimates, with a high estimate of -$0.3 per share and a lower estimate of -$0.41. The company reported an EPS of -$0.4 in the last quarter, which was 14.90% higher than expectations of -$0.47.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. RXST’s latest balance sheet shows that the firm has $159.33M in Cash & Short Term Investments as of fiscal 2021. There were $44.93M in debt and $11.08M in liabilities at the time. Its Book Value Per Share was $4.50, while its Total Shareholder’s Equity was $138.24M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for RXST is Buy with a score of 4.88.

Most Popular

Related Posts